Research & Development Tax Credit (R&D) Articles
Posted by Kristin Re’ on April 08, 2021
Generate cash from your past and future investments to develop or improve software.
Posted by Kristin Re’ on March 05, 2021
The Consolidated Appropriations Act, 2021 (CAA), a coronavirus relief package enacted on December 27, 2020, contains a number of provisions to assist businesses and individuals that have suffered economically from the coronavirus pandemic. Included in the CAA are beneficial provisions for businesses that obtained or qualify to obtain a loan under the Paycheck Protection Program (PPP) and employers that qualify for the Employee Retention Credit (ERC).
Posted by Kristin Re’ on October 21, 2020
Despite the persistent uncertainty, savvy companies can position themselves to outperform their competitors by capitalizing on market shifts and strengthening their core business models. To do so, liquidity will continue to be at a premium, but many companies at this stage should be able to spend a bit in order to reap considerable returns.
Posted by Cory Van Deusen V on September 25, 2020
While free-flowing collaboration and focused innovation have long been lofty ideals of biotech and pharma companies, because of the COVID-19 pandemic, they’re now imperatives to doing business. With new mandates come new funding pressures, a need to get even tougher on pipeline decisions, and a heightened risk environment.
Posted by Brian Kern on January 06, 2020
With the passage of tax reform legislation knows as the Tax Cuts and Jobs Act (TCJA), a significant opportunity exists for investors to defer capital gains tax owed.
Posted by Cory Van Deusen V on June 14, 2019
On April 17, 2019, the IRS and Treasury issued its much anticipated second set of proposed regulations under Internal Revenue Code, Section 1400Z-2, Special rules for capital gains invested in opportunity zones.